Form 8-K - Current report:
SEC Accession No. 0001104659-21-133083
Filing Date
2021-11-02
Accepted
2021-11-02 16:45:36
Documents
12
Period of Report
2021-11-01
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2131716-1_8k.htm   iXBRL 8-K 31308
  Complete submission text file 0001104659-21-133083.txt   205644

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pahc-20211101.xsd EX-101.SCH 3177
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE pahc-20211101_lab.xml EX-101.LAB 34594
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pahc-20211101_pre.xml EX-101.PRE 22705
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2131716-1_8k_htm.xml XML 3674
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36410 | Film No.: 211372102
SIC: 2834 Pharmaceutical Preparations